According to the National Institutes of Health, more than six million Americans, most age 65 or older, may have dementia caused by Alzheimer's disease, a brain disorder known to slowly destroy memory and thinking skills
Nuvaxovid is the first protein-based Covid-19 vaccine authorized for use in Switzerland
This surpasses the number of approvals supported in 2020
Generalized pustular psoriasis is characterized by episodes of widespread eruptions of painful, sterile pustules
Pluss Advanced Technologies (PLUSS), has led the growth of energy storage materials across applications. Their proprietary Phase Change Material has gained wide acceptance in the pharmaceutical, logistics and food industries. The varied demands of the industry during Covid-19 has brought its technology into focus. Samit Jain, MD, PLUSS in conversation with Thomas C Thottathil discusses trends and outlines his plans for the business
Ryaltris is a fixed dose combination nasal spray that combines an antihistamine (Olopatadine) with a steroid (Mometasone Furoate) for treatment of allergic rhinitis
The approval is based on a multi-centre, single-arm, open-label pivotal clinical trial
Clearing 19 biologics for Europe market
Country’s deep scientific talent pool and its growing role as a clinical trial destination makes it central to how Parexel serves sponsors
Prior to joining Cipla, Gambhir built a strong track record across the pharmaceutical and healthcare sectors.
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
